Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Daly-Schveitzer

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Opinion in Oncology|April 20, 2010
Advances in radiotherapy of head and neck cancersYungan Tao, Nicolas Daly-Schveitzer, Antoine Lusinchi, et al.
International Journal of Radiation Oncology, Biology, Physics|June 4, 2013
Replanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinoma: in regard to Yang et alAntonin Levy, Pierre Blanchard, Nicolas Daly-Schveitzer, et al.
Neurology|March 25, 2014
Increased optic nerve radiosensitivity following optic neuritisNicolae Sanda, Francoise Heran, Nicolas Daly-Schveitzer, et al.
Radiation Oncology (London, England)|March 1, 2013
Phase I trial of oral etoposide in combination with radiotherapy in head and neck squamous cell carcinoma - GORTEC 2004-02Yungan Tao, Etienne Bardet, Dominique Rosine, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 17, 2012
Definitive radiotherapy for squamous cell carcinoma of the pyriform sinusPierre Blanchard, Yungan Tao, Ovidiu Veresezan, et al.
Anti-Cancer Drugs|August 22, 2014
Feasibility of radiotherapy or chemoradiotherapy after taxane-based induction chemotherapy for nonoperated locally advanced head and neck squamous cell carcinomasAntonin Levy, Pierre Blanchard, Sara Bellefqih, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 19, 2014
Concurrent use of cisplatin or cetuximab with definitive radiotherapy for locally advanced head and neck squamous cell carcinomasAntonin Levy, Pierre Blanchard, Sara Bellefqih, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 27, 2005
Low-dose intraoperative brachytherapy in soft tissue sarcomas involving neurovascular structureCarmen Llácer, Martine Delannes, Mathieu Minsat, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 24, 2010
A phase I trial combining oral cisplatin (CP Ethypharm) with radiotherapy in patients with locally advanced head and neck squamous cell carcinomaYungan Tao, Keyvan Rezaï, Etienne Brain, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 12, 2011
Randomized phase III trial (GORTEC 98-03) comparing re-irradiation plus chemotherapy versus methotrexate in patients with recurrent or a second primary head and neck squamous cell carcinoma, treated with a palliative intentJacques Tortochaux, Yungan Tao, Elodie Tournay, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Opinion in Oncology|April 20, 2010
Advances in radiotherapy of head and neck cancersYungan Tao, Nicolas Daly-Schveitzer, Antoine Lusinchi, et al.
International Journal of Radiation Oncology, Biology, Physics|June 4, 2013
Replanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinoma: in regard to Yang et alAntonin Levy, Pierre Blanchard, Nicolas Daly-Schveitzer, et al.
Neurology|March 25, 2014
Increased optic nerve radiosensitivity following optic neuritisNicolae Sanda, Francoise Heran, Nicolas Daly-Schveitzer, et al.
Radiation Oncology (London, England)|March 1, 2013
Phase I trial of oral etoposide in combination with radiotherapy in head and neck squamous cell carcinoma - GORTEC 2004-02Yungan Tao, Etienne Bardet, Dominique Rosine, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 17, 2012
Definitive radiotherapy for squamous cell carcinoma of the pyriform sinusPierre Blanchard, Yungan Tao, Ovidiu Veresezan, et al.
Anti-Cancer Drugs|August 22, 2014
Feasibility of radiotherapy or chemoradiotherapy after taxane-based induction chemotherapy for nonoperated locally advanced head and neck squamous cell carcinomasAntonin Levy, Pierre Blanchard, Sara Bellefqih, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 19, 2014
Concurrent use of cisplatin or cetuximab with definitive radiotherapy for locally advanced head and neck squamous cell carcinomasAntonin Levy, Pierre Blanchard, Sara Bellefqih, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 27, 2005
Low-dose intraoperative brachytherapy in soft tissue sarcomas involving neurovascular structureCarmen Llácer, Martine Delannes, Mathieu Minsat, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 24, 2010
A phase I trial combining oral cisplatin (CP Ethypharm) with radiotherapy in patients with locally advanced head and neck squamous cell carcinomaYungan Tao, Keyvan Rezaï, Etienne Brain, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 12, 2011
Randomized phase III trial (GORTEC 98-03) comparing re-irradiation plus chemotherapy versus methotrexate in patients with recurrent or a second primary head and neck squamous cell carcinoma, treated with a palliative intentJacques Tortochaux, Yungan Tao, Elodie Tournay, et al.
Pageof 2